Federal Register / Vol. 82, No. 163 / Thursday, August 24, 2017 / Notices 40161 

ACTION: Notice of Supplemental Award. 

SUMMARY: HRSA announces the award 

of supplemental grants under the Zika 

Response and Preparedness Act to the 

territorial health departments of Puerto 

Rico, American Samoa, and U.S. Virgin 

Islands to address the unmet needs of 

women, children, and families who are 

or may be affected by Zika virus (ZIKV) 

infection. 

SUPPLEMENTARY INFORMATION: 

Intended Recipient of the Award: 

Territorial health departments of Puerto 

Rico, American Samoa, and U.S. Virgin 

Islands. 

Amount of Non-Competitive Awards: 

Approximately $1,050,000. 

CFDA Number: 93.110. 

Authority: Zika Response and 

Preparedness Act (Pub. L. 114–223) and 

Section 501(a)(2) of the Social Security 

Act (42 U.S.C. 701(a)(2)). 

Justification: The current spread of 

ZIKV poses a significant threat to public 

health, including the health of women, 

children, and families who are affected 

by ZIKV infection. ZIKV infection 

during pregnancy can cause serious 

birth defects, especially affecting the 

neurological system of the infant. 

Funding for these awards is available 

under the Zika Response and 

Preparedness Act through Special 

Projects of Regional and National 

Significance (SPRANS) funds. 

The needs of infants and children 

affected by ZIKV are complex. Families, 

health care providers, and public health 

professionals will be required to work 

together to assure that communitybased, comprehensive, high quality 

health and social services are available 

to these children. The support system 

must address the medical needs of these 

children, such as regularly screening 

children who may not be symptomatic 

at birth; coordinate care through a 

medical home; finance care needed by 

children and families; link to 

community-based services; partner with 

families; and eventually address 

transition to adult services. Following 

HRSA’s December 2016 grant awards to 

the territorial health departments of 

Puerto Rico, American Samoa, and U.S. 

Virgin Islands, recipients continued to 

identify pregnant women and infants 

with lab evidence of ZIKV infection that 

led them to refine their response to 

ZIKV. HRSA’s Maternal and Child 

Health Bureau (MCHB) received 

information from the territorial health 

departments of unmet needs in their 

response to ZIKV through monitoring 

site visits, regular communication, and 

prior approval requests. Needs 

identified by recipients included 

additional equipment, personnel, and 

transportation services. With further 

analysis of other federal funding and the 

current epidemiologic data, MCHB 

confirmed additional funding is 

essential to ensure access to services 

and a comprehensive medical home for 

women, children, and families who are 

or may be affected by ZIKV infection. 

Disease burden and the significant 

increase in pregnant women and 

children with lab evidence of ZIKV 

infection in American Samoa and the 

U.S. Virgin Islands was also considered 

as a factor in determining the allocation 

of funds to the territories to address 

unmet needs. The period of 

performance of the supplemental award 

will be September 2017 through 

December 2019. 

FOR FURTHER INFORMATION CONTACT: 

Maria Paz Carlos, Division of State and 

Community Health, Maternal and Child 

Health Bureau, Health Resources and 

Services Administration, 5600 Fishers 

Lane, Room 18N104A, Rockville, 

Maryland 20857; MCarlos@hrsa.gov. 

Grantee/organization name Territory 

FY 2017 

supplemental 

awards 

Puerto Rico Health Department ................................................................ Puerto Rico .................................................................. $52,850 

American Samoa Health Department ....................................................... American Samoa ......................................................... 423,142 

U.S. Virgin Islands Health Department ..................................................... U.S. Virgin Islands ....................................................... 574,008 

Dated: August 18, 2017. 

George Sigounas, 

Administrator. 

[FR Doc. 2017–17883 Filed 8–23–17; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Submission to OMB for 

Review and Approval: Public Comment 

Request; Information Collection 

Request Title: Federal Tort Claims Act 

(FTCA) Program Deeming Applications 

for Health Center Volunteer Health 

Professionals, OMB No. 0906–XXXX, 

New 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement for opportunity for public 

comment on proposed data collection 

projects of the Paperwork Reduction Act 

of 1995, HRSA announces plans to 

submit an Information Collection 

Request (ICR), described below, to the 

Office of Management and Budget 

(OMB). Prior to submitting the ICR to 

OMB, HRSA seeks comments from the 

public regarding the burden estimate, 

below, or any other aspect of the ICR. 

DATES: Comments on this ICR must be 

received no later than September 25, 

2017. 

ADDRESSES: Submit your comments, 

including the ICR Title, to the desk 

officer for HRSA, either by email to 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–5806. 

FOR FURTHER INFORMATION CONTACT: To 

request a copy of the clearance requests 

submitted to OMB for review, email the 

HRSA Information Collection Clearance 

Officer at paperwork@hrsa.gov or call 

(301) 443–1984. 

SUPPLEMENTARY INFORMATION: When 

submitting comments or requesting 

information, please include the 

information request collection title for 

reference, in compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995. 

Information Collection Request Title: 

Federal Tort Claims Act (FTCA) 

Program Deeming Applications for 

Health Center Volunteer Health 

Professionals OMB No. 0906–XXXX— 

New. 

Abstract: Section 224(q) of the Public 

Health Service (PHS) Act (42 U.S.C. 

233(q)), as amended, authorizes the 

‘‘deeming’’ of certain individuals as 

PHS employees for the purposes of 

receiving Federal Tort Claims Act 

(FTCA) coverage. Section 224(q) relates 

to volunteer health professionals (VHPs) 

of Health Center Program grantees that 

have been deemed as PHS employees. 

The Health Center FTCA Program is 

administered by HRSA’s Bureau of 

Primary Health Care (BPHC). 

Sponsoring health centers are required 


rmajette on DSKBCKNHB2PROD with NOTICES
40162 Federal Register / Vol. 82, No. 163 / Thursday, August 24, 2017 / Notices 

by law to submit deeming applications 

in the specified form and manner on 

behalf of named individuals for review 

and approval, resulting in a ‘‘deeming 

determination’’ that includes associated 

FTCA coverage for these individuals. 

Need and Proposed Use of the 

Information: Deeming applications must 

address certain specified criteria 

required by law in order for deeming 

determinations to be issued, and FTCA 

application forms are critical to BPHC’s 

deeming determination process. These 

forms provide BPHC with the 

information essential for application 

evaluation and determination of 

whether an individual meets the 

requirements for deemed PHS employee 

status for the purposes of FTCA 

coverage. Because the 21st Century 

Cures Act extended FTCA coverage to 

VHPs, BPHC will add new FTCA 

application forms for use by health 

centers applying to sponsor volunteers 

to become volunteer health 

professionals with associated FTCA 

coverage for their activities within the 

scope of deemed employment on behalf 

of the health center. 

Likely Respondents: Respondents 

include Health Center Program funds 

recipients seeking deemed PHS 

employee status on behalf of their 

sponsored individuals for purposes of 

FTCA coverage. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install and utilize 

technology and systems for the purpose 

of collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

Total Estimated Annualized Burden 

Hours: 

Form name Number of 

respondents 

Number of 

responses 

per 

respondent 

Total 

responses 

Average 

burden 

per response 

(in hours) 

Total 

burden 

hours 

FTCA Health Center Volunteer Health Professional Program Application ............................................................... 1375 3 4125 2 8250 

Total .............................................................................. 1375 ........................ 4125 ........................ 8250 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Amy McNulty, 

Acting Director, Division of the Executive 

Secretariat. 

[FR Doc. 2017–17926 Filed 8–23–17; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy And 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel NIAID Peer Review Meeting. 

Date: September 18–19, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: The William F. Bolger Center, 9600 

Newbridge Drive, Potomac, MD 20854. 

Contact Person: Julio Aliberti, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, DEA/NIAID/NIH/DHHS, 5601 

Fishers Lane, MSC-9823, Rockville, MD 

20852, 301–761–7322, alibertijc@

niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel NIAID Investigator Initiated 

Program Project Applications (P01). 

Date: September 27, 2017. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Raymond R. Schleef, 

Ph.D., Senior Scientific Review Officer, 

Scientific Review Program, Division of 

Extramural Activities, Room 3E61, National 

Institutes of Health/NIAID, 5601 Fishers 

Lane, MSC 9823, Bethesda, MD 20892–9823, 

(240) 669–5019, schleefrr@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: August 18, 2017. 

Natasha Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–17892 Filed 8–23–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant and/or contract 

proposals applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

and/or contract proposals applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel SEER 

Program. 


rmajette on DSKBCKNHB2PROD with NOTICES